The Globe and Mail reports in its Tuesday, June 23, edition that CCL Industries is a packaging and specialty label company serving consumer, health care, automotive and industrial markets. The Globe's guest columnist Anij Anand writes in the Number Cruncher column that CCL's three-year average return on capital of 14.9 per cent and five-year average net debt-to-EBITDA ratio of 1.1 suggest solid profitability with manageable leverage. The company's relatively low EBITDA growth volatility of 4.6 per cent also points to a business with less cyclical earnings risk. CCL may appeal to investors who are looking for a balanced compounder with a decent dividend yield of 1.5 per cent. The Globe reported on Sept. 18, 2024, Nov. 15, 2024, Nov. 14, 2025, and May 15, 2026, that RBC Capital Markets analyst Arthur Nagorny had reaffirmed his "outperform" call for CCL. The Class B shares could then be had for $80.86, $77.12, $87.49 and $86.54. The Globe reported on March 18, 2026, that National Bank rated CCL "outperform." It was then worth $84.80.